Trials / Completed
CompletedNCT00818610
Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia
Beta-lactam Monotherapy Versus Beta-lactam - Macrolide Association as Empiric Antibiotherapy Strategies in Non-severe Hospitalized Community-acquired Pneumonia: a Randomized, Non-inferiority, Open Trial.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 601 (actual)
- Sponsor
- Swiss National Fund for Scientific Research · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether a monotherapy with a Beta-Lactam is not inferior to an association of a Beta-Lactam and a macrolide in treating adult patients with community-acquired pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Beta lactam (amoxicillin / clav. acid OR cefuroxime) | 1.2 g 4x/d OR 1.5 g 3x/d IV |
| DRUG | Beta-lactam (amoxicillin / clav. acid OR cefuroxime) AND macrolide (clarithromycin) | 1.2 g 4x/d OR 1.5 g 3x/d IV AND 0.5 g 2x/d IV/PO |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2013-01-01
- Completion
- 2013-04-01
- First posted
- 2009-01-07
- Last updated
- 2013-04-25
Locations
6 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00818610. Inclusion in this directory is not an endorsement.